Assignee
ELLODI PHARMACEUTICALS L P
US·11 granted patents·8 pending applications·49 citations·filing 2018–2025
Top patents by PatentIndex Score
19 records- 0197US11266598B2Orally administered corticosteroid compositionsELLODI PHARMACEUTICALS L P·Filed 2021·Granted Mar 8, 2022·6 cites·30 claims
- 0297US11260061B2Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitisELLODI PHARMACEUTICALS L P·Filed 2021·Granted Mar 1, 2022·7 cites·30 claims
- 0397US11246828B2Orally administered corticosteroid compositionsELLODI PHARMACEUTICALS L P·Filed 2020·Granted Feb 15, 2022·6 cites·16 claims
- 0496US11166961B2Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitisELLODI PHARMACEUTICALS L P·Filed 2019·Granted Nov 9, 2021·7 cites·21 claims
- 0596US2026083754A1Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitisELLODI PHARMACEUTICALS L P·Filed 2025·Application pending·0 cites
- 0695US12059494B2Methods of treating eosinophilic esophagitisELLODI PHARMACEUTICALS L P·Filed 2023·Granted Aug 13, 2024·3 cites·36 claims
- 0795US11896710B2Methods of treating eosinophilic esophagitisELLODI PHARMACEUTICALS L P·Filed 2021·Granted Feb 13, 2024·4 cites·29 claims
- 0895US11684571B2Methods of treating eosinophilic esophagitisELLODI PHARMACEUTICALS L P·Filed 2021·Granted Jun 27, 2023·5 cites·24 claims
- 0995US2026083668A1Orally administered corticosteroid compositionsELLODI PHARMACEUTICALS L P·Filed 2025·Application pending·0 cites
- 1094US11026887B2Methods of treating eosinophilic esophagitisELLODI PHARMACEUTICALS L P·Filed 2018·Granted Jun 8, 2021·9 cites·30 claims
- 1192US12310976B2Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitisELLODI PHARMACEUTICALS L P·Filed 2021·Granted May 27, 2025·1 cites·20 claims
- 1292US12290598B2Orally administered corticosteroid compositionsELLODI PHARMACEUTICALS L P·Filed 2022·Granted May 6, 2025·1 cites·34 claims
- 1387US2025170057A1Methods of treating eosinophilic esophagitisELLODI PHARMACEUTICALS L P·Filed 2024·Application pending·0 cites
- 1484US12447157B2Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitisELLODI PHARMACEUTICALS L P·Filed 2025·Granted Oct 21, 2025·0 cites·38 claims
- 1584US2026027129A1Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitisELLODI PHARMACEUTICALS L P·Filed 2025·Application pending·0 cites
- 1683US2026021041A1Orally administered corticosteroid compositionsELLODI PHARMACEUTICALS L P·Filed 2025·Application pending·0 cites
- 1775US2025322925A1Methods of managing eosinophilic esophagitisELLODI PHARMACEUTICALS L P·Filed 2024·Application pending·0 cites
- 1860US2024207288A1Methods of treating esophageal stricturesELLODI PHARMACEUTICALS L P·Filed 2022·Application pending·0 cites
- 1953US2022347189A1Methods of treating eosinophilic esophagitis and reducing candidiasisELLODI PHARMACEUTICALS L P·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ELLODI PHARMACEUTICALS L P files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →